Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

The global supply of COVID-19 vaccines remains limited. An understanding of the immune response that is predictive of protection could facilitate rapid licensure of new vaccines. Data from a randomized efficacy trial of the ChAdOx1 nCoV-19 (AZD1222) vaccine in the United Kingdom was analyzed to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Shuo, Phillips, Daniel J., White, Thomas, Sayal, Homesh, Aley, Parvinder K., Bibi, Sagida, Dold, Christina, Fuskova, Michelle, Gilbert, Sarah C., Hirsch, Ian, Humphries, Holly E., Jepson, Brett, Kelly, Elizabeth J., Plested, Emma, Shoemaker, Kathryn, Thomas, Kelly M., Vekemans, Johan, Villafana, Tonya L., Lambe, Teresa, Pollard, Andrew J., Voysey, Merryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604724/
https://www.ncbi.nlm.nih.gov/pubmed/34588689
http://dx.doi.org/10.1038/s41591-021-01540-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604724/
https://www.ncbi.nlm.nih.gov/pubmed/34588689
http://dx.doi.org/10.1038/s41591-021-01540-1

Ejemplares similares